Circulating messenger RNA of α-fetoprotein: A possible risk factor of recurrence after resection of hepatocellular carcinomaJENG, Kuo-Shyang; SHEEN, I-Shyan; TSAI, Yi-Chun et al.Archives of surgery (Chicago, IL. 1960). 2004, Vol 139, Num 10, pp 1055-1060, issn 0004-0010, 6 p.Article

The Clinical Relevance of the Expression of the Ratio of Laminin-5 Subchains Messenger RNA of Hepatocellular Carcinoma to Non-Cancerous Liver Remnant: A Prospective StudyJENG, Kuo-Shyang; SHEEN, I-Shyan; JENG, Wen-Juei et al.Hepato-gastroenterology. 2011, Vol 58, Num 110-11, pp 1680-1686, issn 0172-6390, 7 p.Article

Isolated Resection of the Caudate Lobe Harboring Hepatocellular Carcinoma in the Paracaval Portion of the Cirrhotic Liver without Complete Interruption of Hepatic Outflow ― An Alternative Surgical ApproachJENG, Kuo-Shyang; JENG, Wen-Juei; SHEEN, I-Shyan et al.Hepato-gastroenterology. 2011, Vol 58, Num 106, pp 546-550, issn 0172-6390, 5 p.Article

Splenic infarction complicated by splenic artery occlusion after N-butyl-2-cyanoacrylate injection for gastric varices: case reportYU, Li-Kuang; HSU, Chao-Wei; TSENG, Jeng-Hwei et al.Gastrointestinal endoscopy. 2005, Vol 61, Num 2, pp 343-345, issn 0016-5107, 3 p.Article

Endotoxemia contributes to the immune paralysis in patients with cirrhosisLIN, Chun-Yen; TSAIL, I-Fan; HO, Yu-Pin et al.Journal of hepatology. 2007, Vol 46, Num 5, pp 816-826, issn 0168-8278, 11 p.Article

Epidemiological characteristics, risk factors, and clinical manifestations of acute non-A-E HepatitisCHU, Chia-Ming; LIN, Deng-Yn; YEH, Chau-Ting et al.Journal of medical virology. 2001, Vol 65, Num 2, pp 296-300, issn 0146-6615Article

A strong association between down-regulation of HLA-DR expression and the late mortality in patients with severe acute pancreatitisHO, Yu-Pin; SHEEN, I.-Shyan; CHIU, Cheng-Tang et al.The American journal of gastroenterology. 2006, Vol 101, Num 5, pp 1117-1124, issn 0002-9270, 8 p.Article

Emergence and takeover of precore-stop mutant prior to exacerbation of e antigen-negative chronic hepatitis B after withdrawal of lamivudine therapyYEH, Chau-Ting; LIN, Wei-Pin; HSU, Chao-Wei et al.Journal of medical virology. 2006, Vol 78, Num 7, pp 906-910, issn 0146-6615, 5 p.Article

Tenofovir Disoproxil Fumarate (TDF), Emtricitabine/ TDF, and Entecavir in Patients with Decompensated Chronic Hepatitis B Liver DiseaseLIAW, Yun-Fan; SHEEN, I-Shyan; BUTI, Maria et al.Hepatology (Baltimore, Md.). 2011, Vol 53, Num 1, pp 62-72, issn 0270-9139, 11 p.Article

Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinomaLIN, Shi-Ming; YU, Ming-Lung; LEE, Chuan-Mo et al.Journal of hepatology. 2007, Vol 46, Num 1, pp 45-52, issn 0168-8278, 8 p.Article

Prospective randomized controlled study of interferon-alpha in preventing hepatocellular carcinoma recurrence after medical ablation therapy for primary tumorsLIN, Shi-Ming; LIN, Chun-Jung; HSU, Chao-Wei et al.Cancer. 2004, Vol 100, Num 2, pp 376-382, issn 0008-543X, 7 p.Article

A sustained virological response to interferon or interferon/ribavirin reduces hepatocellular carcinoma and improves survival in chronic hepatitis C : a nationwide, multicentre study in TaiwanYU, Ming-Lung; LIN, Shi-Ming; CHUANG, Wan-Long et al.Antiviral therapy (London). 2006, Vol 11, Num 8, pp 985-994, issn 1359-6535, 10 p.Article

Hepatitis C virus infection facilitates gallstone formationCHANG, Te-Sheng; SING KAI LO; SHYR, Hueih-Yuan et al.Journal of gastroenterology and hepatology. 2005, Vol 20, Num 9, pp 1416-1421, issn 0815-9319, 6 p.Article